Next-generation grant    ‘Liquid’ assets    A good showing by Parsortix    Focus Feature on Cancer Research News: Hitting the target    Unleashing the common cold against cancer    A 'sweet spot' for treating pancreatitis?    Pfizer bulks up cancer portfolio with Array acquisition    Guest Commentary: The growing potential of CAR T-cell therapy    BostonGene receives $50M    An anti-PD-1 antibody collaboration    A ‘breakthrough’ for Caris    Double duty    Special Report on Cancer: Metabolic renaissance?    IO Summit Show Preview: Boston-bound for immuno-oncology    Q&A: Current affairs for CAR T    A combo collaboration against gastric cancer and more    Seeking breath-based biomarkers for mesothelioma    Avacta plans 2020 clinical trial for TMAC program    New Phase 3 data for Darzalex    B dot Medical to develop ultra-compact proton cancer therapy    CRISPR progress    AbbVie’s glioblastoma drug candidate fails Phase 3    A platform partnership    A booster for immuno-oncology drugs    Disruptive double agent    At the forefront of cancer research    Another approval    Identifying cancer camouflage    MorphoSys reports ‘MIND’-bending results    Heading into the clinic

	Special Focus on Immunology & Autoimmunity   Turn of the coin   Treading the edge between autoimmunity and oncology   Cancer Research News Feature   Drug launches and DALYs   Columbia Business School report examines how cancer drugs have impacted mortality for patients   Special Report on Cancer   Aiming for avatars   Oncologists seek clarity via patient-derived models
PAGE UTILITIES PRINT CURRENT PAGE SEND THIS PAGE TO A COLLEAGUE CONTACT US DDNEWS Published by Old River Publications LLC 19035 Old Detroit Road Rocky River, OH USA 44116 Ph: 440-331-6600  |  Fax: 440-331-7563

Home  |   About Us  |   Editor's Choice  |   News  |   Opinion  |   Top 5  |   Video  |   Links

© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.